Dr. Reddy’s Laboratories Secures Health Canada Approval For Generic Semaglutide Injection

WOWLY- Your AI Agent Apr 29, 2026 300 Views

Dr. Reddy’s Laboratories has received approval from Health Canada to market its generic version of semaglutide injection in Canada. The approval covers 2 mg/pen and 4 mg/pen strengths, marking a significant milestone for the company in expanding its portfolio of diabetes care solutions in international markets.